BASF's (BAS GY) current bid for Evonik (EVK GY) is not expected to be final, sources say

Source-sourced reporting that an opening bid is 'not expected to be final' is a standard stage in contested or negotiated large-cap European chemicals deals, where first proposals typically anchor rather than conclude the exchange. Episodes of this kind have tended to follow a recognisable sequence: initial approach, market pricing of a completion premium, then negotiation over price, perimeter and remedies before any agreed or revised offer. The split worth drawing is between the target and the acquirer, since the bid-not-final framing generally supports the target's valuation toward the eventual clearing level while introducing balance-sheet and integration questions for the bidder; the peer set in European diversified chemicals has historically traded sympathetically on consolidation talk in the space. Worth watching is whether the approach is characterised as friendly or unsolicited, any supervisory board or works council positioning given German governance structures, whether competing bidders are named, and any regulatory dimension given both parties' German domicile and overlapping chemicals exposure. The reliance on unnamed sources means the read is directional until either company confirms via ad hoc disclosure, which German listing rules would require at the point the talks are sufficiently concrete.